Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid
2. 7-(3-aminopyrrolin-1-yl)-1-(2,4-diflurophenyl)-1.4-dihydro-6-fluoro-4-oxo-1,8-napthyridine-3-carboxylic Acid
3. A 60969
4. A 61827
5. A-60969
6. A-61827
7. A-64730
8. T 3262
9. T-3262
10. Tosufloxacin
11. Tosufloxacin Citric Anhydride
12. Tosufloxacin Tosilate
13. Tosufloxacin, 4-toluene Sulfonate
1. 115964-29-9
2. Tosufloxacin Tosilate
3. Tosufloxacin Tosilate [jan]
4. Ozex
5. 100490-94-6
6. T 3262
7. No6nm634eh
8. Tosufloxacin Toluenesulfonic Acid
9. Chebi:77605
10. 115964-29-9 (tosylate)
11. Tosufloxacin Toluenesulfonate Hydrate
12. 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic Acid;4-methylbenzenesulfonic Acid
13. T-3262
14. Dsstox_cid_27820
15. Dsstox_rid_82583
16. Dsstox_gsid_47842
17. 1,8-naphthyridine-3-carboxylic Acid, 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, 4-methylbenzenesulfonate
18. 1,8-naphthyridine-3-carboxylic Acid, 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, 4-methylbenzenesulfonate (1:1)
19. 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid Tosylate
20. 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid Tosylate
21. Cas-115964-29-9
22. Ncgc00167536-01
23. Tosufloxacin 100 Microg/ml In Acetonitrile
24. Unii-no6nm634eh
25. A 64730
26. Tosufloxacin Monotosylate
27. Tflx P-toluenesulfonate
28. Rac-tosufloxacin Tosylate
29. (rs)-tosufloxacin Tosylate
30. (+-)-tosufloxacin Tosylate
31. Racemic Tosufloxacin Tosylate
32. 1,8-naphthyridine-3-carboxylic Acid, 7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, Mono(4-methylbenzenesulfonate)
33. Mls001401369
34. Schembl676101
35. Tosufloxacin P-toluenesulfonate
36. Chembl104270
37. Dtxsid8047842
38. Hms2051c14
39. Hms2232a12
40. Hms3374f01
41. Hms3393c14
42. Bcp07014
43. Tox21_112533
44. Tosufloxacin Tosilate [mart.]
45. Tosufloxacin Tosilate [who-dd]
46. Tox21_112533_1
47. Ccg-100872
48. Nc00122
49. Ncgc00167536-03
50. 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic Acid 4-methylbenzenesulfonate
51. As-13355
52. Smr000469195
53. Tosufloxacin Toluenesulfonate [mi]
54. Ft-0675303
55. T2506
56. F75633
57. T-3940
58. Tosufloxacin Toluenesulfonate, (+/-)-
59. 490t366
60. A-64730
61. A908843
62. J-003351
63. Tosufloxacin, Antibiotic For Culture Media Use Only
64. Q27147207
65. Tosufloxacin Tosylate, Vetranal(tm), Analytical Standard
66. 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid 4-methylbenzenesulfonic Acid Salt
67. 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid Compound With 4-methylbenzenesulfonic Acid (1:1)
68. Rac-1-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5-oxo-5,8-dihydro-1,8-naphthyridin-2-yl]pyrrolidin-3-aminium 4-methylbenzenesulfonate
69. Rac-7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid 4-methylbenzenesulfonate
| Molecular Weight | 576.5 g/mol |
|---|---|
| Molecular Formula | C26H23F3N4O6S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 4 |
| Exact Mass | 576.12904013 g/mol |
| Monoisotopic Mass | 576.12904013 g/mol |
| Topological Polar Surface Area | 163 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 915 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tosufloxacin Tosylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tosufloxacin Tosylate, including repackagers and relabelers. The FDA regulates Tosufloxacin Tosylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tosufloxacin Tosylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tosufloxacin Tosylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tosufloxacin Tosylate supplier is an individual or a company that provides Tosufloxacin Tosylate active pharmaceutical ingredient (API) or Tosufloxacin Tosylate finished formulations upon request. The Tosufloxacin Tosylate suppliers may include Tosufloxacin Tosylate API manufacturers, exporters, distributors and traders.
click here to find a list of Tosufloxacin Tosylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tosufloxacin Tosylate Drug Master File in Japan (Tosufloxacin Tosylate JDMF) empowers Tosufloxacin Tosylate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tosufloxacin Tosylate JDMF during the approval evaluation for pharmaceutical products. At the time of Tosufloxacin Tosylate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tosufloxacin Tosylate suppliers with JDMF on PharmaCompass.
Tosufloxacin Tosylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tosufloxacin Tosylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tosufloxacin Tosylate GMP manufacturer or Tosufloxacin Tosylate GMP API supplier for your needs.
A Tosufloxacin Tosylate CoA (Certificate of Analysis) is a formal document that attests to Tosufloxacin Tosylate's compliance with Tosufloxacin Tosylate specifications and serves as a tool for batch-level quality control.
Tosufloxacin Tosylate CoA mostly includes findings from lab analyses of a specific batch. For each Tosufloxacin Tosylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tosufloxacin Tosylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tosufloxacin Tosylate EP), Tosufloxacin Tosylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tosufloxacin Tosylate USP).
LOOKING FOR A SUPPLIER?
